Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (101-110 of 749) with videos related to

Pageof 75
Sort By:
Biologics : Targets & Therapy|August 27, 2009
The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complexMassimo Franchini, Giuseppe Lippi
Journal of Thrombosis and Thrombolysis|August 6, 2011
Immune tolerance induction for patients with severe hemophilia A: a critical literature reviewMassimo Franchini, Giuseppe Lippi
Blood Transfusion = Trasfusione Del Sangue|June 12, 2012
Sports anaemia: facts or fiction?Cosimo Ottomano, Massimo Franchini
BMC Medicine|January 17, 2015
The intriguing relationship between the ABO blood group, cardiovascular disease, and cancerMassimo Franchini, Giuseppe Lippi
Expert Review of Hematology|November 13, 2014
NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombastheniaMassimo Franchini, Giuseppe Lippi
Life (Basel, Switzerland)|May 28, 2022
Antibodies and SARS-CoV-2: New Data on Diagnostics and TherapeuticsDaniele Focosi, Massimo Franchini
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 30, 2023
Convalescent plasma regulation: A message in a bottle to the societies and regulatory authorities outside the USDaniele Focosi, Massimo Franchini
Mayo Clinic Proceedings|May 7, 2021
Safety of Convalescent Plasma TransfusionMassimo Franchini, Claudia Glingani
Mayo Clinic Proceedings|August 6, 2021
How Safe Is COVID-19 Convalescent Plasma?Massimo Franchini, Mario Cruciani
Thrombosis Research|February 5, 2023
SARS-CoV-2 infection, vaccination and acquired hemophilia: ReplyMassimo Franchini, Daniele Focosi
Pageof 75

Showing results (101-110 of 749) with videos related to

Sort By:
Pageof 75
Biologics : Targets & Therapy|August 27, 2009
The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complexMassimo Franchini, Giuseppe Lippi
Journal of Thrombosis and Thrombolysis|August 6, 2011
Immune tolerance induction for patients with severe hemophilia A: a critical literature reviewMassimo Franchini, Giuseppe Lippi
Blood Transfusion = Trasfusione Del Sangue|June 12, 2012
Sports anaemia: facts or fiction?Cosimo Ottomano, Massimo Franchini
BMC Medicine|January 17, 2015
The intriguing relationship between the ABO blood group, cardiovascular disease, and cancerMassimo Franchini, Giuseppe Lippi
Expert Review of Hematology|November 13, 2014
NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombastheniaMassimo Franchini, Giuseppe Lippi
Life (Basel, Switzerland)|May 28, 2022
Antibodies and SARS-CoV-2: New Data on Diagnostics and TherapeuticsDaniele Focosi, Massimo Franchini
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 30, 2023
Convalescent plasma regulation: A message in a bottle to the societies and regulatory authorities outside the USDaniele Focosi, Massimo Franchini
Mayo Clinic Proceedings|May 7, 2021
Safety of Convalescent Plasma TransfusionMassimo Franchini, Claudia Glingani
Mayo Clinic Proceedings|August 6, 2021
How Safe Is COVID-19 Convalescent Plasma?Massimo Franchini, Mario Cruciani
Thrombosis Research|February 5, 2023
SARS-CoV-2 infection, vaccination and acquired hemophilia: ReplyMassimo Franchini, Daniele Focosi
Pageof 75